Literature DB >> 31659693

Induction of p73, Δ133p53, Δ160p53, pAKT lead to neuroprotection via DNA repair by 5-LOX inhibition.

Shashank Shekhar1, Sharmistha Dey2.   

Abstract

The inflammatory process plays a key role in neurodegenerative disorder. The inflammatory molecule, 5-lipooxygenase (5-LOX), protein is involved in the pathologic phenotype of AD which includes Aβ amyloid deposition and tau hyperphosphorylation. This study aims to identify the mechanistic role in neuroprotection by 5-LOX inhibitor in neurotoxic SH-SY5Y cell line model by evaluating different cell survival pathway. The neurotoxic SH-SY5Y cells were developed by the treatment of Aβ25-35. The cells were then treated with 5-LOX peptide inhibitor, YWCS to prevent neurotoxicity reported earlier from our lab. The effect of 5-LOX inhibition on cell survival pathways were determined by western blot experiment with different doses of peptide by using polyclonal anti body of p53, anti-Akt and anti-phosphorylated Akt. Immunoprecipitation and mass spectroscopic studies were done to identify the altered proteins appeared on the blot. Over expression of phosphorylated Akt and 3 bands on p53 lane blot other than p53 were observed. Three bands were identified as isoforms of p53 which correspond to p73, Δ133p53 and Δ160p53 in the cells treated only with 80 µM of YWCS compare to untreated cells. However, no alteration of total p53 and Akt were observed in treated cells. The results exposed the novel mechanistic pathway of neuroprotection by 5-LOX inhibition is likely to be mediated by DNA DSB repair through p53 isoforms and PI3K/Akt pathway. Our finding has opened a new window in the therapeutic approach for the prevention of AD.

Entities:  

Keywords:  Alzhemier’s disease; DNA DSB repair; p73; Δ133p53; Δ160p53

Mesh:

Substances:

Year:  2019        PMID: 31659693     DOI: 10.1007/s11033-019-05127-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  15 in total

Review 1.  DNA repair in organelles: Pathways, organization, regulation, relevance in disease and aging.

Authors:  Pierre Boesch; Frédérique Weber-Lotfi; Noha Ibrahim; Vladislav Tarasenko; Anne Cosset; François Paulus; Robert N Lightowlers; André Dietrich
Journal:  Biochim Biophys Acta       Date:  2010-10-13

2.  Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript.

Authors:  Virginie Marcel; Stéphane Perrier; Mustapha Aoubala; Sylvain Ageorges; Michael J Groves; Alexandra Diot; Kenneth Fernandes; Sudhir Tauro; Jean-Christophe Bourdon
Journal:  FEBS Lett       Date:  2010-10-13       Impact factor: 4.124

3.  5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation.

Authors:  Alfonso Catalano; Sabrina Rodilossi; Paola Caprari; Vincenzo Coppola; Antonio Procopio
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

4.  Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

Authors:  M A Lovell; S P Gabbita; W R Markesbery
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

Review 5.  The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage.

Authors:  Lu Gong; Hongjian Gong; Xiao Pan; Changqing Chang; Zhao Ou; Shengfan Ye; Le Yin; Lina Yang; Ting Tao; Zhenhai Zhang; Cong Liu; David P Lane; Jinrong Peng; Jun Chen
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

7.  Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.

Authors:  Ying Liu; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 7.996

8.  PEG-PEI/siROCK2 Protects Against Aβ42-Induced Neurotoxicity in Primary Neuron Cells for Alzheimer Disease.

Authors:  Yunyun Liu; Xingyi Yang; Qingfeng Lei; Zhong Li; Jingyang Hu; Xiaojun Wen; Huijun Wang; Zhonglin Liu
Journal:  Cell Mol Neurobiol       Date:  2015-03-17       Impact factor: 5.046

9.  5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.

Authors:  Xian-Kun Tu; Hua-Bin Zhang; Song-Sheng Shi; Ri-Sheng Liang; Chun-Hua Wang; Chun-Mei Chen; Wei-Zhong Yang
Journal:  Neurochem Res       Date:  2016-07-05       Impact factor: 3.996

10.  p73 coordinates with Δ133p53 to promote DNA double-strand break repair.

Authors:  Hongjian Gong; Yuxi Zhang; Kunpeng Jiang; Shengfan Ye; Shuming Chen; Qinghe Zhang; Jinrong Peng; Jun Chen
Journal:  Cell Death Differ       Date:  2018-03-06       Impact factor: 15.828

View more
  4 in total

Review 1.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

2.  Beyond Tripeptides Two-Step Active Machine Learning for Very Large Data sets.

Authors:  Alexander van Teijlingen; Tell Tuttle
Journal:  J Chem Theory Comput       Date:  2021-04-27       Impact factor: 6.006

Review 3.  Distinct p63 and p73 Protein Interactions Predict Specific Functions in mRNA Splicing and Polyploidy Control in Epithelia.

Authors:  Julian M Rozenberg; Olga S Rogovaya; Gerry Melino; Nickolai A Barlev; Alexander Kagansky
Journal:  Cells       Date:  2020-12-25       Impact factor: 6.600

Review 4.  P63 and P73 Activation in Cancers with p53 Mutation.

Authors:  Bi-He Cai; Yun-Chien Hsu; Fang-Yu Yeh; Yu-Rou Lin; Rui-Yu Lu; Si-Jie Yu; Jei-Fu Shaw; Ming-Han Wu; Yi-Zhen Tsai; Ying-Chen Lin; Zhi-Yu Bai; Yu-Chen Shih; Yi-Chiang Hsu; Ruo-Yu Liao; Wei-Hsin Kuo; Chao-Tien Hsu; Ching-Feng Lien; Chia-Chi Chen
Journal:  Biomedicines       Date:  2022-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.